当您想到生产应用中的机器人时，汽车和包装行业的大规模操作往往会迅速跳跃。在波士顿，孟菲斯和哥斯达黎加，医疗设备制造商的生产设施Tegra医疗可能不是一个非常小的操作，但它的迷你工作单元是运算符与自动化的界面。因此，典型的工业机器人在公司寻求扩展其生产运营的自动化时，公司不是公司的可行选择。然而，小型的协作机器人被证明是合适的。
Driven by a need to lower costs and speed up production with high-volume robotic technology, Tegra Medical was looking for a scalable robotic platform that it could implement, engineer and maintain on its own without the need for a third-party integrator. Based on the Tegra Medical’s cost, implementation and use parameters,通用机器人致辞“所有这些领域”，Tegra Medical的工程总监Halblenkhorn说。加上“通用机器人的准确性和设计”远远远远超出市场上的其他任何人。“
迄今为止，Tegra医疗已建立了三个机器人工作组。前两种细胞产生动脉闭合装置，每个电池都使用UR5机器人进行机器趋势。两个UR5S从进料器拾取空白，在车床，磨床和输送机之间移动它们，在一个循环中，现在只需10秒即可完成使用手动劳动的22秒。
Tegra医疗uses a UR10 robot in a mixed model cell to feed three different part numbers simultaneously into the same machining cycle. “Running three different products on three different operations is unusual not just for us, but also in the industry; [it’s not common] to have a mixed model cell feeding three products simultaneously,” says Blenkhorn.
He notes that, being in the medical industry, Tegra Medical can’t just “change our process without notifying our customers and going through validation activity. But by replacing an operator with the robot, we just changed the handling of components between the processes. That was a huge win for us.”
Blenkhorn also points to the company’s improved product quality resulting from the UR5 and UR10 implementations. “With the UR robots, we only get a few rejects per day. Before, that number was significantly higher,” he says.
In addition to the higher levels of quality helping to dispel Tegra Medical’s concerns about the Universal Robots’ accuracy, the company’s concerns about repeatability have also been alleviated after having the first UR5 workcell produce its one millionth part in less than a year.
Blenkhorn指出，鉴于机器人的低成本，易于实施和工程，以及它们的高度准确性和重复性，机器人的平均投资期收益在短短三到六个月之间。
To see a video of the Universal Robots UR5 and UR10 in action at Tegra Medical, see the video below.
